InMode (INMD) EBIT Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | -35.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.61% |
| Dec 31, 2025 | -6.72% |
| Sep 30, 2025 | -56.70% |
| Jun 30, 2025 | 24.94% |
| Mar 31, 2025 | -13.67% |
| Dec 31, 2024 | -45.62% |
| Sep 30, 2024 | 3.99% |
| Jun 30, 2024 | -71.17% |
| Mar 31, 2024 | -55.87% |
| Dec 31, 2023 | -14.45% |
| Sep 30, 2023 | -13.65% |
| Jun 30, 2023 | 29.09% |
| Mar 31, 2023 | 17.11% |
| Dec 31, 2022 | 10.61% |
| Sep 30, 2022 | 19.39% |
| Jun 30, 2022 | 18.46% |
| Mar 31, 2022 | 30.77% |
| Dec 31, 2021 | 52.80% |
| Sep 30, 2021 | 75.19% |
| Jun 30, 2021 | 348.31% |
| Mar 31, 2021 | 122.11% |
| Dec 31, 2020 | 93.28% |
| Sep 30, 2020 | 57.01% |
| Jun 30, 2020 | -42.59% |
| Mar 31, 2020 | 21.36% |
| Dec 31, 2019 | 1,296.50% |
| Sep 30, 2019 | 94.97% |
| Jun 30, 2019 | 105.78% |